Chemoinformaics analysis of (2-METHYL-5-PROPAN-2-YL-2-BICYCLO[3.1.0]HEXANYL) ACETATE
Molecular Weight | 196.29 | nRot | 2 |
Heavy Atom Molecular Weight | 176.13 | nRig | 11 |
Exact Molecular Weight | 196.146 | nRing | 2 |
Solubility: LogS | -4.856 | nHRing | 0 |
Solubility: LogP | 4.091 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 34.9799 |
nHD | 0 | BPOL | 22.6681 |
QED | 0.634 |
Synth | 2.324 |
Natural Product Likeliness | 0.12 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.003 |
HIA | 0.004 |
CACO-2 | -4.363 |
MDCK | 0.0000284 |
BBB | 0.19 |
PPB | 0.878198 |
VDSS | 2.073 |
FU | 0.115939 |
CYP1A2-inh | 0.967 |
CYP1A2-sub | 0.942 |
CYP2c19-inh | 0.916 |
CYP2c19-sub | 0.718 |
CYP2c9-inh | 0.67 |
CYP2c9-sub | 0.798 |
CYP2d6-inh | 0.912 |
CYP2d6-sub | 0.901 |
CYP3a4-inh | 0.453 |
CYP3a4-sub | 0.352 |
CL | 4.469 |
T12 | 0.455 |
hERG | 0.028 |
Ames | 0.017 |
ROA | 0.13 |
SkinSen | 0.877 |
Carcinogencity | 0.22 |
EI | 0.983 |
Respiratory | 0.868 |
NR-Aromatase | 0.005 |
Antiviral | Yes |
Prediction | 0.62467 |